Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

NCT05799274 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Pancreatic Ductal Adenocarcinoma
Non-small Cell Lung Cancer (NSCLC)
Esophageal Squamous Cell Carcinoma
Cervical Cancer
Endometrial Cancer
Ovarian Cancer

Interventions

DRUG: RAD301 ([68Ga]-RAD301)

Sponsor

Radiopharm Theranostics, Ltd